Economic Impact of a triptan Rx-To-OTC Switch in Six EU Countries

Open Access

Peer-reviewed

Research Article

Aurelie Millier ,

* Email: ami@creativ-ceutical.com

Affiliation Health Economics and Outcomes Research Department, Creativ-Ceutical, Paris, France
⨯
Joshua Cohen,

Affiliation Tufts Center for the Study of Drug Development, Tufts University, Boston, Massachusetts, United States of America
⨯
Mondher Toumi

Affiliation Unité de Formation et de Recherche d'Odontologie, Université Claude Bernard Lyon I, Lyon, France
⨯

Reader Comments (0)

Migraine
Is the Subject Area "Migraine" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Economic impact analysis
Is the Subject Area "Economic impact analysis" applicable to this article?

Thanks for your feedback.
France
Is the Subject Area "France" applicable to this article?

Thanks for your feedback.
Italy
Is the Subject Area "Italy" applicable to this article?

Thanks for your feedback.
Poland
Is the Subject Area "Poland" applicable to this article?

Thanks for your feedback.
Spain
Is the Subject Area "Spain" applicable to this article?

Thanks for your feedback.